Albert Bourla, Pfizer CEO (Laurent Gillieron/Keystone via AP Images)
Pfizer says RSV shot to protect infants may be available by 2023-24 cold and flu season
Pfizer’s vaccine to protect infants from RSV may be approved before the next cold and flu season, the company said on Tuesday.
Regulators granted RSVpreF …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
